Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Document:GBR Directive 93/42/EEC 11-Oct-2007

From GxPlex

Revision as of 12:54, 16 July 2026 by GxPlexBot (talk | contribs) (Migrate to Template:DocumentData for PageForms (GxPlexBot))
Jump to: navigation, search


Document information
Reference GBR Directive 93/42/EEC 11-Oct-2007
Validity area GBR
Scope(s) MD
Document name Directive 93/42/EEC
Version / Revision 11-Oct-2007
Status Current
Document type Legal act
Language(s) EN
Description COUNCIL DIRECTIVE 93/42/EEC - of 14 June 1993

concerning medical devices

Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors

References

 ScopeDocument partLanguagePreview
GBR Directive 93/42/EEC 11-Oct-2007 ANNEX X 2.1MDANNEX X 2.1EN2. Clinical investigations

2.1. Objectives The objectives of clinical investigation are:

— to verify that, under normal conditions of use, the per…
GBR Directive 93/42/EEC 11-Oct-2007 Annex VIII 1. ; 2.MDAnnex VIII 1. ; 2.ENSTATEMENT CONCERNING DEVICES FOR SPECIAL PURPOSES 1.For custom-made devices or for devices intended for clinical investigations the manufacturer or hi…
GBR Directive 93/42/EEC 11-Oct-2007 Annex VIII 1. ; 2. ; 2.2MDAnnex VIII 1. ; 2. ; 2.2ENSTATEMENT CONCERNING DEVICES FOR SPECIAL PURPOSES 1.For custom-made devices or for devices intended for clinical investigations the manufacturer or hi…
GBR Directive 93/42/EEC 11-Oct-2007 Annex XMDAnnex XENCLINICAL EVALUATION

[…]

2.3.5.All serious adverse events must be fully recorded and immediately notified to all competent authorities of the Member St…
GBR Directive 93/42/EEC 11-Oct-2007 Annex X 2.2MDAnnex X 2.2EN2.2.Ethical considerations Clinical investigations must be carried out in accordance with the Helsinki Declaration adopted by the 18th World Medical A…
GBR Directive 93/42/EEC 11-Oct-2007 Annex X 2.3.7MDAnnex X 2.3.7EN2.3.7. The written report, signed by the medical practitioner or other authorized person responsible, must contain a critical evaluation of all the da…
GBR Directive 93/42/EEC 11-Oct-2007 Article 15 1. - 4.MDArticle 15 1. - 4.ENClinical investigation 1. In the case of devices intended for clinical investigations, the manufacturer or the authorised representative, established …
GBR Directive 93/42/EEC 11-Oct-2007 Article 15 6. - 7.-001MDArticle 15 6. - 7.ENClinical Investigation

[...]

6. The Member States shall, if necessary, take the appropriate steps to ensure public health and public policy. Where a c…
GBR Directive 93/42/EEC 11-Oct-2007 Article 15 6. - 7.-002MDArticle 15 6. - 7.ENClinical Investigation

[...]

6. The Member States shall, if necessary, take the appropriate steps to ensure public health and public policy. Where a c…
GBR Directive 93/42/EEC 11-Oct-2007 Article 9MDArticle 9ENClassification

1. Devices shall be divided into Classes I, IIa, IIb and III. Classification shall be carried out in accordance with Annex IX.

2. In th…


References

Reference Scope Document part Language Preview
Reference:GBR Directive 93/42/EEC 11-Oct-2007 ANNEX X 2.1 MD ANNEX X

2.1 || EN || 2. Clinical investigations 2.1. Objectives The objectives of clinical investigation are: — to verify that, under normal conditions of use, the performance of the devices conform to those referred to ...

Reference:GBR Directive 93/42/EEC 11-Oct-2007 Article 9 MD Article 9 EN Classification 1. Devices shall be divided into Classes I, IIa, IIb and III. Classification shall be carried out in accordance with Annex IX. 2. In the event of a dispute between the manufacturer and ...
Reference:GBR Directive 93/42/EEC 11-Oct-2007 Annex VIII 1. ; 2. MD Annex VIII

1. ; 2. || EN || STATEMENT CONCERNING DEVICES FOR SPECIAL PURPOSES 1.For custom-made devices or for devices intended for clinical investigations the manufacturer or his authorized representative must draw up the ...

Reference:GBR Directive 93/42/EEC 11-Oct-2007 Article 15 1. - 4. MD Article 15

1. - 4. || EN || Clinical investigation 1. In the case of devices intended for clinical investigations, the manufacturer or the authorised representative, established in the Community, shall follow the procedure ...

Reference:GBR Directive 93/42/EEC 11-Oct-2007 Annex X MD Annex X EN CLINICAL EVALUATION […] 2.3.5.All serious adverse events must be fully recorded and immediately notified to all competent authorities of the Member States in which the clinical investigation is being ...
Reference:GBR Directive 93/42/EEC 11-Oct-2007 Article 15 6. - 7.-001 MD Article 15

6. - 7. || EN || Clinical Investigation [...] 6. The Member States shall, if necessary, take the appropriate steps to ensure public health and public policy. Where a clinical investigation is refused or halted by a ...

Reference:GBR Directive 93/42/EEC 11-Oct-2007 Annex VIII 1. ; 2. ; 2.2 MD Annex VIII

1. ; 2. ; 2.2 || EN || STATEMENT CONCERNING DEVICES FOR SPECIAL PURPOSES 1.For custom-made devices or for devices intended for clinical investigations the manufacturer or his authorized representative[F8 established in the ...

Reference:GBR Directive 93/42/EEC 11-Oct-2007 Article 15 6. - 7.-002 MD Article 15

6. - 7. || EN || Clinical Investigation [...] 6. The Member States shall, if necessary, take the appropriate steps to ensure public health and public policy. Where a clinical investigation is refused or halted by a ...

Reference:GBR Directive 93/42/EEC 11-Oct-2007 Annex X 2.3.7 MD Annex X

2.3.7 || EN || 2.3.7. The written report, signed by the medical practitioner or other authorized person responsible, must contain a critical evaluation of all the data collected during the clinical investigation.

Reference:GBR Directive 93/42/EEC 11-Oct-2007 Annex X 2.2 MD Annex X

2.2 || EN || 2.2.Ethical considerations Clinical investigations must be carried out in accordance with the Helsinki Declaration adopted by the 18th World Medical Assembly in Helsinki, Finland, in 1964, as last ...